This suggests that Ct-ash1 may act as a molecular switch between Ct-soxB1/Ct-ngn-mediated NPC proliferation and Ct-neuroD/Ct-elav1-mediated differentiation. The gene discussed is ELAVL1; the disease is nasopharyngeal carcinoma.